NICM
INGN icon

Neo Ivy Capital Management’s Inogen INGN Stock Holding History

Neo Ivy Capital Management’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-902
Closed -$86K – 339
2019
Q1 		$86K Buy
+902
New +$113K 0.05% 232

Other funds holding INGN

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Neo Ivy Capital Management's INGN Position: Q2 2019 in Review

Neo Ivy Capital Management sold out of Inogen (INGN) in Q2 2019, closing a stake of 902 shares — an estimated $86K sold.

Neo Ivy Capital Management first reported a position in INGN in Q1 2019 and held it in 1 quarter. The position peaked at $86K in Q1 2019. 197 funds tracked by Wall St. Rank hold INGN as of Q2 2019.

  • Neo Ivy Capital Management reported no remaining Inogen position as of Q2 2019 after selling out during the quarter.
  • Neo Ivy Capital Management sold 902 Inogen shares in Q2 2019, an estimated $86K.
  • Neo Ivy Capital Management first reported a position in Inogen in Q1 2019 and held it in 1 quarter.
  • Neo Ivy Capital Management's Inogen position peaked at $86K in Q1 2019.
  • 197 funds tracked by Wall St. Rank held Inogen as of Q2 2019.

Based on Neo Ivy Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.